In summary, we successfully identified the CD8+ T cells and cDC1 populations in tumors and TdLNs from B16-OVA tumor-bearing Bcl9/Bcl9l deficiency mice using scRNA-seq. This evidence concerns the gene BCL9L and neoplasm.